Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
about
Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancerDiagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy: a meta-analysis using a hierarchical regression model.Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma modelCross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancerConsequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer.Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer.Diagnostic evaluation of solid pancreatic masses.The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseasesNew developments in the early diagnosis of pancreatic cancer.Imaging modalities for characterising focal pancreatic lesions.The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.[Combined PET-MRI of the abdomen].Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours
P2860
Q26827392-121A8A3F-DFA9-4C4C-89C9-29242262866FQ34194318-ED46A3EE-F4FD-4472-93C1-0BBF44209E7AQ34540997-AADA8397-66B0-4D6B-88B4-330389F5AA41Q35169358-8FCD56A9-A21A-4B57-82FE-69D695018695Q36235666-6052473C-7FD8-4A6F-9147-52CD631FB52EQ37259570-85587796-0174-4BAD-811F-5B52F749E09AQ38133421-F1E8256B-7157-4F9F-A063-3690DA0FF99AQ38136661-133E26C7-F1E5-43A7-9C41-79CAE653C0D9Q38784810-7CFE8090-A814-4283-B0F5-296697BFBE77Q38834240-3D87BEAD-6565-460F-A42A-9D67090A6FABQ46876969-A3E2E3AE-E51E-4FB6-8B9F-88EA5FEF4C99Q52987725-D3549F1A-EAB8-4F16-A4D1-486BF44F8248Q57767529-C23CB8E9-D750-491F-88F8-9C418C8C9B68
P2860
Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Value of contrast-enhanced 18F ...... c cancer: a prospective study.
@en
Value of contrast-enhanced 18F ...... c cancer: a prospective study.
@nl
type
label
Value of contrast-enhanced 18F ...... c cancer: a prospective study.
@en
Value of contrast-enhanced 18F ...... c cancer: a prospective study.
@nl
prefLabel
Value of contrast-enhanced 18F ...... c cancer: a prospective study.
@en
Value of contrast-enhanced 18F ...... c cancer: a prospective study.
@nl
P2093
P2860
P50
P1476
Value of contrast-enhanced 18F ...... ic cancer: a prospective study
@en
P2093
Antoine Rosset
Arnaud D Roth
Christoph D Becker
Jean-Pierre Willi
Leo Bühler
Osman Ratib
Pascal Bucher
Philippe Morel
Sylvain Terraz
P2860
P304
P356
10.1111/J.1440-1746.2010.06525.X
P577
2011-04-01T00:00:00Z